• About Us
    • Overview
    • Management
    • Board of Directors
    • Scientific Advisory Board
    • Contact Us
  • Technology
    • Introduction
    • Anti-CD3 oral immunotherapy
    • Alzheimer's Disease
    • VaxiSome
    • Publications
  • Pipeline
    • Overview
    • NASH
    • Hepatitis C
    • Colitis
    • Alzheimer’s Disease
    • Influenza
  • Partnering
    • Partnering
  • Investors
    • Releases
    • Events
    • Stock Info
    • Financial Reports (Hebrew)
    • Press Clippings
  • Releases
  • Events
  • Stock Info
  • Financial Reports (Hebrew)
  • Press Clippings
  • Investors
  • Stock Info

Stock Info

NasVax has been publicly traded on the Tel Aviv Stock Exchange since December 2005.
  • Disclaimer
  • Privacy Policy
  • Terms of Service
  • Site Map
Site by mantis